Nephrogenic systemic fibrosis with multiple calcification and osseous metaplasia

Acta Dermato-Venereologica

Volumn 88, Issue 6, 2008, Pages 597-600

  Nagai, Yayoi ^a   Hasegawa, Michiko ^a   Shinmi, Kahori ^a   Kishi, Chikako ^a   Tsushima, Yoshito ^a   Endo, Keigo ^a   Okabe, Kazuhiko ^b   Suzuki, Kazuhiro ^a   Ishikawa, Osamu ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Motojima General Hospital   (Japan)

Author keywords

Calcification; Gadolinium; Nephrogenic systemic fibrosis; Osseous metaplasia; Sodium thiosulphate

Indexed keywords

CD34 ANTIGEN; COLLAGEN FIBER; GADODIAMIDE; SODIUM THIOSULFATE;

ADULT; ARM SWELLING; ARTERY OCCLUSION; ARTICLE; CASE REPORT; CHRONIC KIDNEY FAILURE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE INCREASE; DRUG WITHDRAWAL; ERYTHEMA; FASCIA DISEASE; FLEXION CONTRACTURE; HEMODIALYSIS; HISTOPATHOLOGY; HOSPITALIZATION; HUMAN; JAPANESE; LIMB PAIN; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; METAPLASIA; NEPHROGENIC FIBROSING DERMOPATHY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RANGE OF MOTION; SCLERODERMA; SIDE EFFECT; SKIN BIOPSY; SKIN CALCIFICATION; SKIN INDURATION; THROMBOCYTE COUNT;

ADULT; CALCINOSIS; CONTRAST MEDIA; FASCIA; GADOLINIUM DTPA; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MUSCULAR DISEASES; NEPHROGENIC FIBROSING DERMOPATHY; OSSIFICATION, HETEROTOPIC; RENAL DIALYSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 56749100719     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0518     Document Type: Article

References (22)

1. Cowper SE, Robin HS, Steinberg SM, Su LD, Gupta S, Leboit PE. Scleromyxoedema-like cutaneous diseases in renal-dialysis patients. Lancet 2000; 356: 1000-1001.
2. Ting WW, Stone MS, Madison KC, Kurtz K. Nephrogenic fibrosing dermopathy with systemic involvement. Arch Dermatol 2003; 139: 903-939.
3. Mendoza F, Arflett CM, Sandorfi N, Latinis K, Piera-Velazquez S, Jimenez SA. Description of twelve cases of nephrogenic fibrosing dermopathy and review of the literature. Semin Arteritis Rheum 2006; 35: 238-249.
4. Grobner T. Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 2006; 21: 1104-1108.
5. Boyd AS, Zic JA, Abraham JL. Gadolinium deposition in nephrogenic fibrosing dermopathy. J Am Acad Dermatol 2007; 56: 27-30.
6. High WA, Ayers RA, Chandler J, Zito G, Cowper SE. Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis. J Am Acad Dermatol 2007; 56: 21-26.
7. Marckmann P, Skov L, Rossen K, Dupont A, Damholt MB, Heaf JG, Thomsen HS. Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast enhanced magnetic resonance imaging. J Am Soc Nephrol 2006; 17: 2359-2362.
8. Thomsen HS, Morcos SK, Dawson P. Is there a causal relation between the administration of gadolinium based contrast media and the development of nephrogenic systemic fibrosis (NSF)? Clin Radiol 2006; 61: 905-906.
9. Kuo PH, Kanai E, Abu-Alfa AK, Cowper SE. Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis. Radiology 2007; 242: 647-649.
10. Richmond H, Zwerner J, Kim Y, Fiorentino D. Nephrogenic systemic fibrosis. Arch Dermataol 2007; 143: 1025-1030.
11. Pryor JG, Poggioli G, Galatia N, Gust A, Robison J, Samic F, et al. Nephrogenic systemic fibrosis: a clinicopathologic study of six cases. J Am Acad Dermatol 2007; 57: 105-111.
12. Yerram P, Saab G, Karuparthi PR, Hayden MR, Khanna R. Nephrogenic systemic fibrosis: a mysterious disease in patients with renal failure - role of Gadolinium-based contrast media in causation and the beneficial effect of intravenous sodium thiosulfate. Clin J Am Soc Nephrol 2007; 2: 258-263.
13. Cowper SE, Su L, Robin H, Bhawan J, Leboit PE. Nephrogenic fibrosing dermopathy. Am J Dermatopathol 2001; 23: 383-393.
14. Introcaso CE, Hivnor C, Cowper S, Werth VP. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis: a case series of nine patients and review of the literature. Int J Dermatol 2007; 46: 447-452.
15. Levine JM, Taylor RA, Elman LB, Bird SJ, Lavi E, Stolzenberg ED, et al. Involvement of skeletal muscle involvement in dialysis-associated systemic fibrosis (nephrogenic fibrosing dermopathy) Muscle Nerve 2004; 30: 569-577.
16. Evenepoel P, Zeegers M, Segaert S, Claes K, Kuypers D, Maes B, et al. Nephrogenic fibrosing dermopathy: a novel, disabling disorder in patients with renal failure. Nephrol Dial Transplat 2004; 19: 469-473.
17. Gremmels J, Kirk G. Two patients with abnormal skeletal muscle uptake of Tc-99m hydroxymethylene diphosphonate following liver transplant; nephrogenic fibrosing dermopathy and graft vs host disease. Clin Nucl Med 2004; 29: 694-697.
18. Taylor E, Henderson J, Rennke H, Magee CC. Traumatic calsinosis cutis in a dialysis patient. Am J Kidney 2004; 44: 18-21.
19. Edsall L, English J, Teague M, Patterson JW. Calciphylaxis and metastatic calcification associated with nephrogenic fibrosing dermopathy. J Cutan Pathol 2004; 31: 247-253.
20. Lewis KG, Lester BW, Pan TD, Robinson-Bostom L. Nephrogenic fibrosing dermopathy and calciphylaxis with pseudoxanthoma elasticum-like changes. J Cutan Pathol 2006; 33: 695-700.
21. Ruiz-Genao D, Pascual-Lopez M, Fraga S, Aragues M, Garcia-Diez A. Osseous metaplasia in the setting of nephrogenic fibrosing dennopathy. J Cutan Pathol 2005; 32: 172-175.
22. Hershko K, Hull C, Ettefagh L, Nedorost S, Dyson S, Horn T, Gilliam AC. A variant of nephrogenic fibrosing dermopathy with osteoclast-like giant cells: a syndrome of dysregulated matrix remodelling? J Cutan Pathol 2004; 31: 262-265.